About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 935 record(s)
Req # A-2019-001912
Adverse Reaction Report (AER). Report number: E2B_02807309.Organization: Health Canada
March 2020
Req # A-2019-001922
Adverse Reaction Report (AER) for Guanfacine. Report number: E2B_02774351.Organization: Health Canada
March 2020
Req # A-2019-001958
Adverse Reaction Report (AER). Report numbers: E2B_02777617, E2B_02779836.Organization: Health Canada
March 2020
Req # A-2016-000926
All records describing substantive changes to the organizational structure of the Healthy Environments and Consumer Safety Branch for the period July 27, 2016 to October 25, 2016.Organization: Health Canada
February 2020
Req # A-2019-001273
All briefing documents on prescription drug insurance that were prepared for the new Minister from July 1 to October 31, 2019.Organization: Health Canada
February 2020
Req # A-2019-001509
Industrial Hemp Application Guide, Industrial Hemp Regulations, Regulatory Impact Analysis Statement, Canadian Hemp Trade Alliance (CHTA) presentations, Industrial Hemp: Cannabis Tracking and Licensing System User Guide.Organization: Health Canada
February 2020
Req # A-2019-001511
Good Production Practices (GPP) Guidance, Analytical Testing Application Guide, as well as response to correspondence received from an external individual on methodology for laboratory testing for cannabis including second wave products.Organization: Health Canada
February 2020
Req # A-2019-001514
The policy for the Inclusion of Cannabis Varieties on the List of Approved Cultivars and List of Approved Cultivars for the 2019 Growing Season.Organization: Health Canada
February 2020
Req # A-2019-001519
Packaging and labelling guidance documents, recall notices, product guidance document, appealing to youth statement for all types of Cannabis products since the inception of the Cannabis Act. This includes any lists or repositories of acceptable and…Organization: Health Canada
February 2020
Req # A-2019-001565
Access to information request - Engleng Inc. Property: 1805 Saint-François Road, Dorval, Quebec. Any document and information in your files and records concerning (i) the Corporation and/or (ii) the Property.Organization: Health Canada
February 2020